Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Researching Emotions And Cardiac Health: Phase III

Not Applicable

Completed

Conditions: Congestive Heart Failure
Emotions
Patient Compliance

Interventions: Behavioral: PP-based health behavior intervention
Behavioral: MI-based educational control condition

First Posted Date: 2017-07-18

Last Posted Date: 2021-08-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT03220204

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea

Not Applicable

Completed

Conditions: Keratectasia
Keratoconus
Pellucid Marginal Corneal Degeneration

Interventions: Device: Brillouin Ocular Scanner

First Posted Date: 2017-07-18

Last Posted Date: 2022-08-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 85

Registration Number: NCT03220529

Locations: 🇨🇭
Institute for Refractive and Ophthalmic Surgery, Zurich, Switzerland
🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

Not Applicable

Terminated

Conditions: Type 1 Diabetes Mellitus

Interventions: Device: Bihormonal Bionic Pancreas
Device: Insulin Only Bionic Pancreas
Drug: Placebo
Drug: Glucagon

First Posted Date: 2017-07-13

Last Posted Date: 2019-12-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 22

Registration Number: NCT03217175

Locations: 🇺🇸
MGH Diabetes Research Center, Boston, Massachusetts, United States

A 60-seconds Personalized Mindfulness Video Exercise for Patients With Orthopedic Illness

Not Applicable

Completed

Conditions: Orthopaedic Injury
Mindfulness

Interventions: Other: Educational Brochure
Behavioral: 60 Second Video

First Posted Date: 2017-07-11

Last Posted Date: 2018-08-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 125

Registration Number: NCT03212105

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma

Not Applicable

Completed

Conditions: Lymphoma

Interventions: Behavioral: 3RP-Lymphoma

First Posted Date: 2017-07-11

Last Posted Date: 2021-11-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 37

Registration Number: NCT03212261

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant

Phase 4

Terminated

Conditions: End Stage Liver Disease
Hepatitis C

Interventions: Drug: Treatment with Direct Acting Antiviral tablet

First Posted Date: 2017-07-05

Last Posted Date: 2022-07-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 33

Registration Number: NCT03208127

Locations: 🇺🇸
Masschusetts General Hospital, Boston, Massachusetts, United States

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant

Phase 4

Terminated

Conditions: End Stage Heart Disease
Hepatitis C

Interventions: Drug: Clinically prescribed direct acting antiviral

First Posted Date: 2017-07-05

Last Posted Date: 2022-06-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT03208244

Locations: 🇺🇸
Masschusetts General Hospital, Boston, Massachusetts, United States

A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC

Phase 1

Active, not recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Alectinib
Drug: Cobimetinib

First Posted Date: 2017-06-29

Last Posted Date: 2024-04-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT03202940

Locations: 🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients

Not Applicable

Recruiting

Conditions: Mechanical Ventilation Complication
Alveolar Edema
Right Heart Failure
Right Ventricular Dysfunction
Respiratory Distress Syndrome
ARDS, Human
Lung Injury, Acute

Interventions: Procedure: PEEP ARDSnet
Procedure: PEEP LRM

First Posted Date: 2017-06-28

Last Posted Date: 2022-11-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT03202641

Locations: 🇺🇸
Massachussets General Hospital, Boston, Massachusetts, United States

Intraoperative Fentanyl Dose on Respiratory Complications

Conditions: Surgery
Respiratory Complication
Opioid Use
Fentanyl

Interventions: Drug: Fentanyl dose administration

First Posted Date: 2017-06-26

Last Posted Date: 2017-06-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 183396

Registration Number: NCT03198208

Locations: 🇺🇸
The Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy